FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1059
Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113883.3.464.1003.1059 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1059/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1059 |
Version | 20240123 |
Status | active |
Date | 2024-01-23T01:10:32-05:00 |
Name | PotentiallyHarmfulSulfonylureasForOlderAdults |
Title | Potentially Harmful Sulfonylureas for Older Adults |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Sulfonylureas for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes glimepiride and glyburide.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.) |
Resources that use this resource
No resources found
Resources that this resource uses
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.464.1003.1059",
"meta": {
"versionId": "17",
"lastUpdated": "2024-01-24T09:42:32.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "NCQA PHEMUR Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-01-23"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1059",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.464.1003.1059"
}
],
"version": "20240123",
"name": "PotentiallyHarmfulSulfonylureasForOlderAdults",
"title": "Potentially Harmful Sulfonylureas for Older Adults",
"status": "active",
"date": "2024-01-23T01:10:32-05:00",
"publisher": "NCQA PHEMUR",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Sulfonylureas for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes glimepiride and glyburide.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)",
"compose": {
"include": [
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1257"
]
}
]
},
"expansion": {
"identifier": "urn:uuid:3b9cd1ba-029b-4064-8d43-382e9d404718",
"timestamp": "2025-05-23T22:13:49-04:00",
"total": 17,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1361493",
"display": "glimepiride 6 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1361495",
"display": "glimepiride 8 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "153842",
"display": "glimepiride 3 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "197737",
"display": "glyburide 1.25 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "199245",
"display": "glimepiride 1 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "199246",
"display": "glimepiride 2 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "199247",
"display": "glimepiride 4 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "310534",
"display": "glyburide 2.5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "310536",
"display": "glyburide 3 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "310537",
"display": "glyburide 5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "310539",
"display": "glyburide 6 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "314000",
"display": "glyburide 1.5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "647237",
"display": "glimepiride 2 MG / pioglitazone 30 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "647239",
"display": "glimepiride 4 MG / pioglitazone 30 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "861743",
"display": "glyburide 1.25 MG / metformin hydrochloride 250 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "861748",
"display": "glyburide 2.5 MG / metformin hydrochloride 500 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "861753",
"display": "glyburide 5 MG / metformin hydrochloride 500 MG Oral Tablet"
}
]
}
}